Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis.
Supravalvular aortic stenosis (SVAS) is an inherited obstructive vascular disease that affects the aorta, carotid, coronary and pulmonary arteries. Previous molecular genetic data have led to the hypothesis that SVAS results from mutations in the elastin gene, ELN. In these studies, the disease phenotype was linked to gross DNA rearrangements (35 and 85 kb deletions and a translocation) in three SVAS families. However, gross rearrangements of ELN have not been identified in most cases of autosomal dominant SVAS. To define the spectrum of ELN mutations responsible for this disorder, we refined the genomic structure of human ELN and used this information in mutational analyses. ELN point mutations co-segregate with the disease in four familial cases and are associated with SVAS in three sporadic cases. Two of the mutations are nonsense, one is a single base pair deletion and four are splice site mutations. In one sporadic case, the mutation arose de novo. These data demonstrate that point mutations of ELN cause autosomal dominant SVAS.
Li
D Y
DY
Cardiology Division, University of Utah Health Sciences Center, Eccles Institute of Human Genetics, Salt Lake City 84112, USA.
Toland
A E
AE
Boak
B B
BB
Atkinson
D L
DL
Ensing
G J
GJ
Morris
C A
CA
Keating
M T
MT
D001024:Aortic Valve Stenosis / Q000235:genetics*; D003001:Cloning, Molecular; D004252:DNA Mutational Analysis; D017931:DNA Primers / Q000235:genetics; D004549:Elastin / Q000235:genetics*; D005260:Female; D016368:Frameshift Mutation; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D009154:Mutation; D010375:Pedigree; D018807:Polymorphism, Single-Stranded Conformational; D012326:RNA Splicing
D017931:DNA Primers; D004549:Elastin